Anika Therapeutics, Inc. ANIK 37.65
Health Care · NASDAQ · Data as of 2026-07-29
Anika Therapeutics, Inc. (ANIK) has delivered +1.2% annualized revenue growth, n/a earnings growth, and n/a dividend growth over 10 years of data. Ranked #1554 of 1968 stocks overall and #194 of 260 in the Health Care sector by Steady Score.
Industry
Surgical & Medical Instruments
Steady Score
37.65
Overall Rank
#1554 / 1968
Sector Rank
#194 / 260
Revenue CAGR
+1.2%
Earnings CAGR
-
Dividend CAGR
-
?
E/R CAGR Ratio
-
Revenue
Earnings
Dividends
Free Cash Flow
Margin
NET Margin
FCF Margin
Payout Ratio
Payout Ratio
FCF Payout Ratio